Vaccination, especially booster doses, reduces the risk of long COVID by up to 29%, highlighting its critical role in preventing lingering Omicron-era complications.
Icon acquires HumanFirst to boost support for digital tools in clinical trials
As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research